Drug intelligence / Profile preview

Proctosedyl

Development stage
Unknown
Lead developer
Phoenix Laboratories
Modality
Small Molecules
Administration
Rectal, Topical
01

Overview

Proctosedyl is an approved fixed-dose combination medication formulated as an ointment or suppository for the short-term symptomatic relief of hemorrhoids, anal fissures, pruritus ani, and proctitis. It combines four active ingredients with distinct therapeutic actions: hydrocortisone (a mild corticosteroid that reduces inflammation, swelling, and itching), cinchocaine hydrochloride (a potent local anesthetic that blocks voltage-gated sodium channels to provide rapid pain relief and relax sphincteric spasms), framycetin sulfate (an aminoglycoside antibiotic that targets the bacterial 30S ribosomal subunit to prevent or treat secondary bacterial infections), and aesculin (a vasoprotective coumarin glycoside that reduces capillary permeability and fragility). Originally developed by Sanofi (historically Roussel Uclaf) and currently marketed in various regions by sponsors such as Phoenix Laboratories, Proctosedyl provides rapid and multi-targeted relief from anorectal discomfort.

Brand names
Proctosedyl
Other names
aesculin + cinchocaine + framycetin + hydrocortisonecinchocaine + hydrocortisone + framycetin + aesculindibucaine + hydrocortisone + framycetin + esculinesculin + cinchocaine + framycetin + hydrocortisonehydrocortisone + cinchocaine + framycetin + aesculinhydrocortisone + dibucaine + framycetin + esculin
02

Targets

Bacterial RibosomeMMP12 (Macrophage Metalloelastase)GR (Glucocorticoid receptor)HYAL (Hyaluronidase family (HYAL))NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Proctosedyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proctosedyl.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call